In the blood of a total of 14 HCC patients, the percentage of EpCAM+ CTCs was only 8.03%, and post-surgical patients with EpCAM+ CTCs detected showed poor prognosis [144]. This evidence concerns the gene EPCAM and hepatocellular carcinoma.